PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

This study has been completed.

Study NCT00053885 Information provided by Cancer and Leukemia Group B

First Received: February 5, 2003 Last Updated: March 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	June 2006
Primary Completion Date:	July 2005 (Final data collection date for primary outcome measure)

Publications:

Jahan TM, Gu L, Wang X, et al.: Vatalanib (V) for patients with previously untreated advanced malignant mesothelioma (MM): A phase II study by the Cancer and Leukemia Group B (CALGB 30107). [Abstract] J Clin Oncol 24 (Suppl 18): A-7081, 2006.